7326 - 7350 of 7916 Results
Title
Year
-
OPENTitle: Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjectsJournal Name: Neurological ResearchPublisher: Informa UK LimitedVol: 34Issue #: 7Start Page: 669End Page: 676Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1179/1743132812y.0000000063Best OA location URL: https://europepmc.org/articles/pmc3681206?pdf=renderCitation Count: 60
- Förster Resonance Energy Transfer (FRET) Correlates of Altered Subunit Stoichiometry in Cys-Loop Receptors, Exemplified by Nicotinic α4β22012OPENTitle: Förster Resonance Energy Transfer (FRET) Correlates of Altered Subunit Stoichiometry in Cys-Loop Receptors, Exemplified by Nicotinic α4β2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 10022End Page: 10040Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms130810022Best OA location URL: https://www.mdpi.com/1422-0067/13/8/10022/pdf?version=1403144658Citation Count: 22
- Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interaction2012RESTRICTEDTitle: Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interactionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 72End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.07.007Citation Count: 24
-
RESTRICTEDTitle: The PRIPS study: screening battery for subjects at risk for Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 20Issue #: 1Start Page: 102End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2012.03798.xCitation Count: 117
-
OPENTitle: Low nigrostriatal reserve for motor parkinsonism in nonhuman primatesJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 237Issue #: 2Start Page: 355End Page: 362Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.07.008Best OA location URL: https://europepmc.org/articles/pmc3443325?pdf=renderCitation Count: 38
- Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applications2012RESTRICTEDTitle: Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applicationsJournal Name: FEBS LettersPublisher: WileyVol: 586Issue #: 18Start Page: 2826End Page: 2834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.febslet.2012.07.023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2012.07.023Citation Count: 85
-
OPENTitle: Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 597End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318263c443Best OA location URL: https://n.neurology.org/content/neurology/79/6/597.full.pdfCitation Count: 142
- Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)2012OPENTitle: Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Journal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 69Issue #: 20Start Page: 3511End Page: 3527Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00018-012-1071-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00018-012-1071-9.pdfCitation Count: 31
-
OPENTitle: The MAPT H1 haplotype is associated with tangle-predominant dementiaJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 124Issue #: 5Start Page: 693End Page: 704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-012-1017-1Best OA location URL: https://europepmc.org/articles/pmc3608475?pdf=renderCitation Count: 78
-
OPENTitle: Large-scale replication and heterogeneity in Parkinson disease genetic lociJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 7Start Page: 659End Page: 667Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318264e353Best OA location URL: https://europepmc.org/articles/pmc3414661?pdf=renderCitation Count: 124
- Progression of motor and nonmotor features of Parkinson's disease and their response to treatment2012OPENTitle: Progression of motor and nonmotor features of Parkinson's disease and their response to treatmentJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 267End Page: 283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04192.xBest OA location URL: https://europepmc.org/articles/pmc3630747?pdf=renderCitation Count: 158
-
OPENTitle: Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1073End Page: 1078Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.004Best OA location URL: https://europepmc.org/articles/pmc6545886?pdf=renderCitation Count: 31
- GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor2012OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: https://europepmc.org/articles/pmc4208292?pdf=renderCitation Count: 141
-
RESTRICTEDTitle: Anxiety and motor fluctuations in Parkinson's disease: A cross-sectional observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1084End Page: 1088Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.007Citation Count: 85
- Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease2012OPENTitle: Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 10Start Page: 1089End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.06.008Best OA location URL: http://www.prd-journal.com/article/S1353802012002465/pdfCitation Count: 59
- Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response2012OPENTitle: Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress responseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 6Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07860.xBest OA location URL: https://europepmc.org/articles/pmc4135048?pdf=renderCitation Count: 18
- Serotonin transporter inhibition attenuates l‐DOPA‐induced dyskinesia without compromising l‐DOPA efficacy in hemi‐parkinsonian rats2012OPENTitle: Serotonin transporter inhibition attenuates l‐DOPA‐induced dyskinesia without compromising l‐DOPA efficacy in hemi‐parkinsonian ratsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 36Issue #: 6Start Page: 2839End Page: 2848Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2012.08202.xBest OA location URL: https://europepmc.org/articles/pmc3445783?pdf=renderCitation Count: 70
-
OPENTitle: Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 523End Page: 530Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182635645Best OA location URL: https://europepmc.org/articles/pmc3413767?pdf=renderCitation Count: 164
- Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease2012OPENTitle: Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 141Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3003985Best OA location URL: https://europepmc.org/articles/pmc3462009?pdf=renderCitation Count: 470
-
OPENTitle: Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 3Start Page: 243End Page: 248Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31825fdeedBest OA location URL: https://europepmc.org/articles/pmc3398434?pdf=renderCitation Count: 109
-
RESTRICTEDTitle: Animal models of Parkinson's disease: Limits and relevance to neuroprotection studiesJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 1Start Page: 61End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25108Best OA location URL: https://europepmc.org/articles/pmc3517687?pdf=renderCitation Count: 162
- Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug class2012OPENTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://europepmc.org/articles/pmc3589103?pdf=renderCitation Count: 47
-
RESTRICTEDTitle: Gene expression in the Parkinson's disease brainJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 88Issue #: 4Start Page: 302End Page: 312Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.brainresbull.2011.11.016Best OA location URL: https://doi.org/10.1016/j.brainresbull.2011.11.016Citation Count: 39
- P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers2012RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0
- P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease2012RESTRICTEDTitle: P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_21Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.08.089Citation Count: 0